You know those celebrity-favorite weight loss injections? The ones that help people shed pounds but come with a not-so-fun catch: the weight often creeps back on once you stop the shots. Well, a new daily pill might just be the answer to that particular party pooper.
Meet orforglipron. It's already available in the US and could soon be making its way to the UK. Think of it as the friendly follow-up act to your weight loss journey, designed to help you keep those hard-won results.
The Rebound Problem, Solved?
Because, let's be honest, the biggest bummer with GLP-1 injections (like Ozempic or Wegovy) is the dreaded weight rebound. People stop the jabs, and suddenly their body decides it misses those extra pounds. Not ideal. But trials published in Nature Medicine showed participants taking orforglipron daily for a year avoided regaining a significant chunk of their lost weight.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxThis study, funded by Eli Lilly (who also makes the Mounjaro jab), followed 376 participants in the US. They'd already lost weight on GLP-1 injections and then, after stopping their shots, were given either orforglipron or a placebo pill for a year. The result? The orforglipron group kept off over 70% of their initial weight loss. The placebo group? A less impressive 38-50%. Let that satisfying number sink in.
How it Works and Why it Matters
Orforglipron works much like the injections, mimicking a natural hormone that tells your brain, "Hey, we're full!" and keeps your appetite in check. The real kicker? It's significantly cheaper than many current injectable GLP-1 drugs in the US, ringing in at about $149 per month for the lowest dose, compared to some jabs that top $1,000. Which, if you think about it, is both impressive and slightly terrifying.
Dr. Marie Spreckley, a weight management expert at the University of Cambridge, pointed out the obvious appeal: a pill is often just easier to take than a regular injection. She also highlighted that obesity is a chronic condition, often requiring ongoing treatment — possibly even for life, experts suggest. So, a more accessible, daily option could be a big deal.
Sure, there were mild side effects like nausea or constipation, but nothing too dramatic. And Dr. Simon Cork from Anglia Ruskin University called this a "really important study," noting that beyond weight, the drug also helped maintain lower blood pressure, lipids, and blood glucose, potentially reducing long-term health risks like heart disease. Because apparently that's where we are now: popping a pill to keep the weight off and save your heart. Not a bad deal, all things considered.
